Alkem Laboratories is one of India’s largest generic and specialty pharmaceutical company. Also, it has consistently been ranked amongst the top ten pharmaceutical companies in India. Its portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, its dominance in anti-infective segment has remained unchallenged. Some part of its revenue is generated via offshore sales. The company has manufacturing facilities at multiple locations in India and the United States of America. Its upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries.

Business area of the company

The company is one of India’s foremost global pharmaceutical company. The company is engaged in the development, manufacture and marketing of pharmaceuticals with operational footprints across different countries. In India, it has a formidable presence in several therapy segments and consistently features amongst the top ten pharmaceutical companies. Steered by its industry experience of over four decades, it offers high-quality branded generics, generic drugs, active pharmaceutical ingredients and nutraceuticals.

Alkem Laboratories Ltd.

Lupin Ltd.

Aurobindo Pharma Ltd.

Abbott India Ltd.

Zydus Lifesciences Ltd.

Torrent Pharmaceuticals Ltd.

Gland Pharma Ltd.

Ipca Laboratories Ltd.

Biocon Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Ajanta Pharma Ltd.

JB Chemicals & Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.

Piramal Enterprises Ltd.

Laurus Labs Ltd.

Market Cap	55,495 Cr	ROE	21.7%
P/E Ratio(TTM)	38.7	EPS(TTM)	0.0
P/B Ratio	5.6	Dividend Yield	1.1%
Industry P/E	40.7	Book Value	823.2
		Face Value	2.0

Fundamentals